Seeking Alpha

Jefferies says its analysis of Mako Surgical (MAKO +4.2%) points to considerable upside . After...

Jefferies says its analysis of Mako Surgical (MAKO +4.2%) points to considerable upside . After reviewing its free cash flow yield and historical valuation relative to Intuitive Surgical (ISRG +1.2%) and other traditional medical device names, Jefferies believes the shares are significantly undervalued. The firm reiterates a buy at current levels and maintains an Overweight rating on the stock with a $49 price target.
Comments (2)
  • sana5000
    , contributor
    Comments (59) | Send Message
     
    MAKO is a very good company with a bright future... very smart diagnosis on the author's part. In a year, I believe it will be at 40-45
    19 Jun 2012, 05:31 PM Reply Like
  • rich1st
    , contributor
    Comment (1) | Send Message
     
    Have owned ISRG for a long time. They do "soft tissue". MAKO does the hard stuff, ie: bones.( so far hips and knees) Looking forward to a great future for this company.
    20 Jun 2012, 12:00 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs